Universal, no-cost coverage for the drug mifegymiso (also known as RU-486) commenced on 15 January 2018. Mifegymiso, an alternative to surgical abortion, is a combination of mifepristone and... Read More
Universal, no-cost coverage for the drug mifegymiso (also known as RU-486) commenced on 15 January 2018. Mifegymiso, an alternative to surgical abortion, is a combination of mifepristone and... Read More
Effective 1 February 2018, physicians will receive an across-the-board increase of 0.4% to all MSP fees, as well as to service, salary, and sessional contract ranges and rates within those ranges.... Read More
Medical errors can be costly for both patient and hospital. As defined by the Joint Commission (www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf), in order to keep patients safe... Read More
The BCMJ is pleased to introduce our newest Editorial Board member, Dr Yvonne Sin. Dr Sin is a second-year UBC family practice resident who intends to practise full-service family... Read More

In the last few decades, occupational noise has become more widely recognized as a hazard that has resulted in many cases of otherwise preventable hearing loss. According to Statistics Canada,... Read More